Otsuka and Click Initiate Digital Study in Adults with Major Depressive Disorder
Shots:
- Otsuka and Click have reported the initiation of the Mirai study which is a fully remote clinical trial to investigate the effectiveness of digital therapeutics in reducing depressive symptoms in adults diagnosed with MDD who are on antidepressant monotherapy. The study will enroll ~540 patients globally
- The trial will run fully remotely utilizing the Verily Project Baseline platform- a first-of-its-kind trial design for MDD. Participation will be of 10wks. and efficacy will be evaluated as a change from baseline in the MADRS total score
- The companies’ collaboration with Verily enables the trial to proceed efficiently and safely during the pandemic
Ref: Businesswire | Image: Contract Pharma
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com